NCT02381886 2025-11-10A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsNovartisPhase 1 Active not recruiting166 enrolled
NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled